Super Early Bird tickets now available for SynbiTECH 2024. Register today
-
Prokarium
Overview Prokarium develops vaccines against a variety of infectious diseases, basing the immunotherapy on Engineering Biology.Using engineered strains of attenuated bacteria offers a cost-effective solution for the production of oral vaccines and bypasses the need for expensive protein purification steps. Since Prokarium’s Salmonella platform has already been proven safe, the biotech is now expanding into…
-
LabGenius
Overview LabGenius Therapeutics (“LabGenius”) is a next-generation antibody therapeutics company that combines machine learning with automated functional screening to enable the rapid discovery of complex multispecifics. Their lead optimisation platform, EVA™, unlocks high-performing, often non-intuitive molecular designs. EVA™ is both modality and format-agnostic but for their internal pipeline, LabGenius is developing highly selective T-cell engagers for the treatment…
-
Supporting Puraffinity’s groundbreaking SynBio discoveries
Overview Puraffinity are a green technology company incorporated in 2015 focussed on designing smart materials for environmental applications. Their belief is that deep science holds the answers to a myriad of environmental challenges that pose a threat to our planet and wellbeing. Cutting-edge material design coupled with creative engineering can provide a new horizon for…